Mkts

BridgeBio Pharma, Inc.

NASDAQ: BBIO
$78.67+0.74 (+0.95%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
76.6079.83
52-week range
60.5593.42
Today
Open76.70
Previous close78.67
Volume—
Valuation
Market cap15.48B
P/E ratio—
EPS (TTM)-2.91
Income & risk
Dividend / yield—
Beta1.12
Avg volume2.81M
Discussion

BBIO News

Stories mentioning BBIO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue194,515154,178120,700110,565116,6335,8822,7322,168
Cost of Goods Sold9,9398,1076,5633,6532,6392,084598.00598.00
Gross Profit184,576146,071114,137106,912113,9943,7982,1341,570
Operating Expenses
Research & Development126,636116,417112,874111,231111,431130,350120,444114,695
Sales General & Admin163,896158,085137,621129,154106,36594,78268,81959,523
Total Operating Expenses
Operating Income (Loss)(105,956)(139,562)(145,199)(134,278)(104,372)(226,027)(191,750)(175,539)
Interest Income6,2464,3326,2393,8985,3854,6833,2965,195
Interest Expense22,937
Other Expense4,25311,81816,4616,5488,2311,6241,797(632.00)
Pretax Income(186,482)(181,658)(164,254)(75,544)
Tax Provision(120.00)(1,545)2,1000.001,1530.000.00
Net Income (Loss)
Earnings Per Share (Basic)(0.84)0.00(0.95)(0.95)(0.88)0.00(0.86)(0.39)
Earnings Per Share (Diluted)(0.84)0.00(0.95)(0.95)(0.88)0.00(0.86)(0.39)
Weighted Average Shares Outstanding (Basic)194,790191,527191,854190,517190,145186,076188,510187,587
Weighted Average Shares Outstanding (Diluted)194,790191,527191,854190,517190,145186,076188,510187,587

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BBIO

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol BBIO. It last traded at $78.67 (Nov 10, 2026, 4:00 PM ET), up 0.9% on the day. That gives BridgeBio Pharma a market capitalisation of $15.5B.

Over the past 52 weeks BBIO has traded between $60.55 and $93.42.

Revenue for the quarter ended Mar 31, 2026 was $194.5M. Revenue was up 66.8% from $116.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$194.5M—
Dec 31, 2025$154.2M—
Sep 30, 2025$120.7M—
Jun 30, 2025$110.6M—

From BridgeBio Pharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…